ENDRA Life Sciences Inc.·4

Jul 16, 4:06 PM ET

Thornton Michael Milos 4

4 · ENDRA Life Sciences Inc. · Filed Jul 16, 2020

Insider Transaction Report

Form 4
Period: 2020-07-15
Thornton Michael Milos
Chief Technology Officer
Transactions
  • Exercise of In-Money

    Warrants

    2020-07-1526,00024,252 total
    Exercise: $0.87From: 2019-12-11Exp: 2024-12-11Common Stock (26,000 underlying)
  • Exercise of In-Money

    Common Stock

    2020-07-15$0.87/sh+26,000$22,620293,710 total
Footnotes (1)
  • [F1]Includes unvested restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION